Skip to main content
Premium Trial:

Request an Annual Quote

Pharmacopeia Purchases Rights To Distribute MSI Software In Asia-Pacific


PRINCETON, NJ--Pharmacopeia has bought the right to distribute Molecular Simulations software in Japan and other Asia Pacific countries. The $10 million deal was with Teijin, a Japanese chemical and pharmaceutical company. Teijin Molecular Simulations, owned jointly by Molecular Simulations and Teijin, was established in 1992. In 1998, Molecular Simulations became a wholly owned subsidiary of Pharmacopeia.

Joseph Mollica, chairman and CEO of Pharmacopeia, said the agreement will give his company "full control over our distribution strategy in Asia, a market that accounted for 20 percent of our total Molecular Simulations software sales in 1998."

Ryoka Systems, a subsidiary of Mitsubishi Chemical, has been appointed exclusive distributor of Molecular Simulations software in Japan.

Filed under

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.